NeuraWell Therapeutics engages in clinical-stage research and development company for central nervous system (CNS) disorders.
Neurawell Therapeutics has raised $1.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2024.
Neurawell Therapeutics is headquartered in Miami, United States.
NeuraWell Therapeutics engages in clinical-stage research and development company for central nervous system (CNS) disorders.
Neurawell Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurawell Therapeutics — Funding & Investors." VCBacked, June 7, 2024, https://www.vcbacked.co/company/neurawell-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Neurawell Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/neurawell-therapeutics
{{cite web |title=Neurawell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neurawell-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated